HI TECH PHARMACAL CO INC (HITK) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 393 transactions totaling $46.7M, demonstrating a bearish sentiment with -$45.3M in net insider flow. The most recent transaction on Dec 13, 2013 involved a sale of 6,873 shares valued at $296.0K.
No significant insider buying has been recorded for HITK in the recent period.
No significant insider selling has been recorded for HITK in the recent period.
Based on recent SEC filings, insider sentiment for HITK is bearish with an Insider Alignment Score of 2/100 and a net flow of -$45.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at HI TECH PHARMACAL CO INC (HITK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading HITK stock, having executed 393 transactions in the past 90 days. The most active insider is David S. Seltzer (Executive), who has made 77 transactions totaling $17.4M.
Get notified when executives and directors at HITK file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 13, 2013 | M. April Gary | Executive | Sale | 6,873 | $43.06 | $296.0K | |
| Dec 13, 2013 | M. April Gary | Executive | Option Exercise | 3,124 | $31.93 | $99.7K | |
| Dec 13, 2013 | M. April Gary | Executive | Option Exercise | 1,874 | $22.25 | $41.7K | |
| Dec 13, 2013 | M. April Gary | Executive | Option Exercise | 1,875 | $19.59 | $36.7K | |
| Oct 10, 2013 | Seltzer Reuben | Executive | Sale | 11,250 | $43.13 | $485.2K | |
| Oct 10, 2013 | Seltzer Reuben | Executive | Option Exercise | 11,250 | $10.93 | $123.0K | |
| Oct 9, 2013 | S. Seltzer David | Executive | Option Exercise | 75,000 | $14.99 | $1.1M | Large |
| Oct 9, 2013 | S. Seltzer David | Executive | Payment | 26,091 | $43.09 | $1.1M | Large |
| Oct 8, 2013 | S. Seltzer David | Executive | Sale | 23,000 | $43.09 | $991.1K | Large |
| Oct 4, 2013 | M. Goldwyn Martin | Executive | Option Exercise | 1,500 | $24.95 | $37.4K | |
| Oct 4, 2013 | M. Goldwyn Martin | Executive | Sale | 1,500 | $43.10 | $64.7K | |
| Oct 3, 2013 | J. Peters William | Executive | Option Exercise | 6,250 | $5.83 | $36.4K | |
| Oct 3, 2013 | J. Peters William | Executive | Sale | 21,250 | $43.11 | $916.1K | Large |
| Oct 3, 2013 | J. Peters William | Executive | Option Exercise | 15,000 | $18.87 | $283.1K | |
| Oct 2, 2013 | Seltzer Reuben | Executive | Option Exercise | 11,250 | $13.50 | $151.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 192 | $46.0M | 75.9% |
Exercise(M) | 142 | $11.5M | 18.9% |
Payment(F) | 2 | $2.4M | 4.0% |
Purchase(P) | 5 | $705.8K | 1.2% |
Other(J) | 16 | $0 | 0.0% |
Gift(G) | 36 | $0 | 0.0% |
Insider selling pressure at HI TECH PHARMACAL CO INC has increased, with 15 insiders executing 393 transactions across all time. Total sales of $46.0M significantly outpace purchases of $705.8K, resulting in a net outflow of $45.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.